Teladoc Health Q3 EPS USD -0.15

By Reuters News

Oct 28 (Reuters) - Teladoc Health Q3 adjusted EBITDA USD 79.358 million vs. IBES estimate USD 67.8 million.

  • Q3 net income USD -26.934 million
  • Q3 revenue USD 605.102 million vs. IBES estimate USD 588.5 million
  • Q3 basic EPS USD -0.15
  • outlook Q4 adjusted EBITDA USD 74-100 million vs. IBES estimate USD 87.1 million
  • outlook FY adjusted EBITDA USD 277-303 million vs. IBES estimate USD 278.9 million
  • outlook Q4 EPS USD -0.23 to -0.03
  • outlook FY revenue USD 2,395-2,441 million vs. IBES estimate USD 2,406 million
  • outlook FY EPS USD -0.95 to -0.75
  • outlook Q4 revenue USD 569-615 million vs. IBES estimate USD 597.4 million

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk